Literature DB >> 4598841

Amoxicillin: in vitro and pharmacological studies.

G P Bodey, J Nance.   

Abstract

Amoxicillin is a new semisynthetic penicillin which is active in vitro against gram-positive cocci (except penicillin G-resistant Staphylococcus aureus) and most isolates of Proteus mirabilis and Escherichia coli. Its in vitro activity is quite similar to ampicillin, but it produces higher serum levels after oral administration. The mean peak serum levels of amoxicillin in 11 normal volunteers were 2.30 mug/ml after 125 mg, 3.43 mug/ml after 250 mg, 6.75 mug/ml after 500 mg, and 9.90 mug/ml after 1 g. About 70% of the drug was excreted in the urine during the first 6 hr.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4598841      PMCID: PMC444222          DOI: 10.1128/AAC.1.4.358

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Ampicillin activity in vitro and absorption and excretion in normal young men.

Authors:  J O KLEIN; M FINLAND
Journal:  Am J Med Sci       Date:  1963-05       Impact factor: 2.378

2.  New antistaphylococcal antibiotics. Comparative in vitro and in vivo activity of cephalothin, nafcillin, cloxacillin, oxacillin, and methicillin.

Authors:  S SIDELL; R E BURDICK; J BRODIE; R J BULGER; W M KIRBY
Journal:  Arch Intern Med       Date:  1963-07

3.  Pharmacological studies of 6 (D(-) -amino-p-hydroxyphenylacetamido) penicillanic acid in humans.

Authors:  H C Neu; E B Winshell
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

4.  In vitro antimicrobial activity of 6(D(-) -amino-p-hydroxyphenylacetamido) penicillanic acid, a new semisynthetic penicillin.

Authors:  H C Neu; E B Winshell
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

5.  Semiautomatic microtechnique for serial dilution-antibiotic sensitivity testing in the clinical laboratory.

Authors:  J D MacLowry; H H Marsh
Journal:  J Lab Clin Med       Date:  1968-10

6.  Single oral dose ampicillin-probenecid treatment of gnorrhea in the male.

Authors:  P A Kvale; T F Keys; D W Johnson; K K Holmes
Journal:  JAMA       Date:  1971-03-01       Impact factor: 56.272

7.  -amino-p-hydroxybenzylpenicillin (BRL 2333), a new semisynthetic penicillin: absorption and excretion in man.

Authors:  E A Croydon; R Sutherland
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

8.  -amino-p-hydroxybenzylpenicillin (BRL 2333), a new semisynthetic penicillin: in vitro evaluation.

Authors:  R Sutherland; G N Rolinson
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

9.  -amino-p-hydroxybenzylpenicillin (BRL 2333), a new broad-spectrum semisynthetic penicillin: in vivo evaluation.

Authors:  P Acred; P A Hunter; L Mizen; G N Rolinson
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970
  9 in total
  17 in total

1.  Triple crossover study on absorption and excretion of ampicillin, pivampicillin, and amoxycillin.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

Review 2.  Amoxycillin: a preliminary report of its pharmokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1974       Impact factor: 9.546

3.  Sequence effect on ampicillin blood levels noted in an amoxicillin, ampicillin, and epicillin triple crossover study.

Authors:  A Philipson; L D Sabath; B Rosner
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

4.  Oral amoxicillin in acute uncomplicated gonorrhea.

Authors:  L Bayne; D Tamblyn; J Ruedy; R I Ogilvie
Journal:  Can Med Assoc J       Date:  1974-10-05       Impact factor: 8.262

5.  Absorption and disposition kinetics of amoxicillin in normal human subjects.

Authors:  A Arancibia; J Guttmann; G González; C González
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

6.  Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin, and amoxycillin.

Authors:  J Sjövall; L Magni; T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

7.  Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration.

Authors:  D A Spyker; R J Rugloski; R L Vann; W M O'Brien
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

8.  Triple crossover study on absorption and excretion of ampicillin, talampicillin, and amoxycillin.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

9.  Clinical and laboratory evaluation of amoxicillin (BRL 2333) in the treatment of urinary tract infections.

Authors:  F G Middleton; D M Poretz; R J Duma
Journal:  Antimicrob Agents Chemother       Date:  1973-07       Impact factor: 5.191

10.  Bioequivalence evaluation of two capsule formulations of amoxicillin in healthy adult male bangladeshi volunteers: A single-dose, randomized, open-label, two-period crossover study.

Authors:  Ashik Ullah; Mohammad Abul Kalam Azad; Rebeka Sultana; Maruf Mohammad Akbor; Ahasanul Hasan; Mahbub Latif; Abul Hasnat
Journal:  Curr Ther Res Clin Exp       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.